GovChime
Notice ID: df612f6f438e40aebd02c5f1f0b52571Combined Synopsis/Solicitation

KDEL receptor antibodies

Archived on September 16, 2020. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
2:00 PM UTC−04:00
Posted
August 27, 2020
Notice type
Combined Synopsis/Solicitation
Set-aside
Small Business Set Aside - Total
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Place of performance
Baltimore, 21224
Last updated
Sep 25, 2026

Identifiers

Solicitation number
75N95020Q00192
Notice ID
df612f6f438e40aebd02c5f1f0b52571

Description

Amendment 1: The above referenced solicitation is hereby amended to respond to technical questions submitted. The following questions and responses are hereby provided: 1. Question: What is the form of the antigens while shipping? Response: Antigens will not be provided. 2. Question: How will the antigens be supplied? As purified proteins or will you need peptide antigen design and synthesis? Response: Antigens will not be provided. NIDA is looking for a company that can identify peptide antigens and synthesize them. The due date for quotations remains unchanged. Original description: The purpose of this requirement is to produce monoclonal and polyclonal KDEL receptor (KDELR) antibodies for each of the subtypes of KDELR (KDELR1, KDELR2, KDELR3) separately. Please see the attached Combined Synopsis Solicitation.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:75N95020Q00192
  1. Market Research
  2. Combined Synopsis
  1. Market ResearchJul 29, 2020

    KDEL receptor antibodies

    Notice 8ebea6ed07964bc9985bfd01609cac87 on SAM.gov

  2. 2×
    Combined SynopsisCurrentAug 24, 2020

    KDEL receptor antibodies

    Notice df612f6f438e40aebd02c5f1f0b52571 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95020Q00192

Archive Date

Sep 16, 2020

Office Address

Bethesda, MD, 20892